Cargando…
miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors worldwide. Clinical success is suboptimal owing to late diagnosis, limited treatment options, high recurrence rates, and the development of drug resistance. MicroRNAs (miRNAs), a range of small endogenous non-coding RNAs t...
Autores principales: | Yan, Hang, Tang, Shengjie, Tang, Shoujun, Zhang, Jun, Guo, Haiyang, Qin, Chao, Hu, Haiyang, Zhong, Chuan, Yang, Li, Zhu, Yunhe, Zhou, Haining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640411/ https://www.ncbi.nlm.nih.gov/pubmed/36386184 http://dx.doi.org/10.3389/fphar.2022.949566 |
Ejemplares similares
-
Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives
por: Guo, Haiyang, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects
por: Tang, Shengjie, et al.
Publicado: (2022) -
Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions
por: Tang, Jinxin, et al.
Publicado: (2022) -
Dietary stilbenes as modulators of specific miRNAs in prostate cancer
por: Levenson, Anait S.
Publicado: (2022) -
miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
por: Hon, Kha Wai, et al.
Publicado: (2018)